Angiotensin-Converting Enzyme Inhibitors Concept

subject area of

• 24-h ambulatory blood pressure readings and associations with albuminuria in youth with type 2 diabetes: A cross sectional analysis from the iCARE cohort  Journal Articles
• A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL)  Journal Articles
• A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction  Journal Articles
• A population‐based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors  Journal Articles
• A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.  Journal Articles
• A review of heart failure treatment.  Journal Articles
• ACE Inhibition in Stable Coronary Artery Disease  Journal Articles
• ACE Inhibition in secondary prevention: are the results controversial?  Journal Articles
• ACE Inhibitors in Heart Failure  Journal Articles
• ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study  Journal Articles
• ACE inhibitors for myocardial infarction and unstable angina  Journal Articles
• ASSOCIATION BETWEEN PSYCHOTROPIC DRUG USE AND HEART FAILURE THERAPY IN ELDERLY LONG‐TERM CARE RESIDENTS  Journal Articles
• Abnormal renal medullary response to angiotensin II in SHR is corrected by long-term enalapril treatment  Journal Articles
• Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials  Journal Articles
• Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study  Journal Articles
• Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction  Journal Articles
• Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes  Journal Articles
• Adjunctive therapy for myocardial infarction.  Journal Articles
• Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry  Journal Articles
• Albuminuria and Decline in Cognitive Function<subtitle>The ONTARGET/TRANSCEND Studies</subtitle><alt-title>Albuminuria and Decline in Cognitive Function</alt-title>  Journal Articles
• Albuminuria and Rapid Loss of GFR and Risk of New Hip and Pelvic Fractures  Journal Articles
• Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)  Journal Articles
• An Evaluation of the Safety of Continuing Trastuzumab Despite Overt Left Ventricular Dysfunction  Journal Articles
• Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation  Journal Articles
• Angiotensin Blockade Does Not Affect Fibrosis Progression in Recurrent Hepatitis C After Liver Transplantation  Journal Articles
• Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma  Journal Articles
• Angiotensin Converting Enzyme Inhibitor Dialyzability and Outcomes in Older Patients Receiving Hemodialysis  Journal Articles
• Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials  Journal Articles
• Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin  Journal Articles
• Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease  Journal Articles
• Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction  Journal Articles
• Angiotensin-converting enzyme inhibitor meta-analysis provides misleading conclusion  Journal Articles
• Angiotensin-converting enzyme inhibitor-induced angioedema: Still unrecognized  Journal Articles
• Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis  Journal Articles
• Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy  Journal Articles
• Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials  Journal Articles
• Angiotensin-converting-enzyme inhibitors in early pregnancy  Journal Articles
• Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials  Journal Articles
• Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors?  Journal Articles
• Anti-ischaemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trials.  Journal Articles
• Antiatherosclerotic Effects of ACE Inhibitors  Journal Articles
• Antihypertensive Drug Prescribing and Persistence Among New Elderly Users: Implications for Persistence Improvement Interventions  Journal Articles
• Antihypertensive effects of perindopril treatment in adult spontaneously hypertensive rats.  Journal Articles
• Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis  Journal Articles
• Are Patients with Inflammatory Bowel Disease at Increased Risk of Coronary Artery Disease?  Journal Articles
• Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke  Journal Articles
• Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events  Journal Articles
• Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes  Journal Articles
• Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis  Journal Articles
• Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes  Journal Articles
• Association of egg intake with blood lipids, cardiovascular disease, and mortality in 177,000 people in 50 countries  Journal Articles
• Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation  Journal Articles
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data  Journal Articles
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.  Journal Articles
• Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure  Journal Articles
• Blockade of the renin–angiotensin–aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: A systematic review and meta analysis of randomized controlled trials  Journal Articles
• Blocking the renin–angiotensin system: dual- versus mono-therapy  Journal Articles
• Blood HER2 and Uromodulin as Causal Mediators of CKD  Journal Articles
• Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)  Journal Articles
• Blood pressure and cardiovascular risk in the HOPE study  Journal Articles
• Blood pressure control rates with an antihypertensive regimen including trandolapril in a canadian usual-care setting  Journal Articles
• Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis  Journal Articles
• Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system  Journal Articles
• Blood-pressure reduction and cardiovascular risk in HOPE study  Journal Articles
• Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease  Journal Articles
• Canadian Cardiovascular Society Quality Indicators for Heart Failure  Journal Articles
• Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and design  Journal Articles
• Cardiovascular Risk in Patients with Early Renal Insufficiency  Journal Articles
• Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk  Journal Articles
• Cardiovascular and metabolic benefits of ACE inhibition: moving beyond blood pressure reduction.  Journal Articles
• Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk  Journal Articles
• Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke  Journal Articles
• Clinical decision making and the expected value of information  Journal Articles
• Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin  Journal Articles
• Clinical experience in protecting the failing heart.  Journal Articles
• Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure—Assessment of Reduction in Mortality and morbidity (CHARM) programme  Journal Articles
• Clinical trials, the renin angiotensin system and atrial fibrillation  Journal Articles
• Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.  Journal Articles
• Community management of heart failure.  Journal Articles
• Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study  Conferences
• Comparative Effects of Losartan and Enalapril on Exercise Capacity and Clinical Status in Patients With Heart Failure fn1fn1This study was supported by a grant from Merck Research Laboratories, West Point, Pennsylvania.  Journal Articles
• Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures  Journal Articles
• Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study  Journal Articles
• Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure  Journal Articles
• Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure  Journal Articles
• Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure  Journal Articles
• Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi/ARB on the histology and function of renal allografts  Journal Articles
• Contemporary Trends in Evidence-based Treatment for Acute Myocardial Infarction  Journal Articles
• Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry  Journal Articles
• Contemporary medical management of left ventricular dysfunction and congestive heart failure.  Journal Articles
• Continuous Flow Immobilized Enzyme Reactor–Tandem Mass Spectrometry for Screening of AChE Inhibitors in Complex Mixtures  Journal Articles
• Control of vascular changes by renin–angiotensin–aldosterone system in salt-sensitive hypertension  Journal Articles
• Coronary artery disease - Impact of ramipril on the incidence of atrial fibrillation: Results of the Heart Outcomes Prevention Evaluation study  Journal Articles
• Correction: Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury  Journal Articles
• Cost Implications of the Use of Ramipril in High-Risk Patients Based on the Heart Outcomes Prevention Evaluation (HOPE) Study  Journal Articles
• Cost-effectiveness of β-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada  Journal Articles
• Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension  Journal Articles
• Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective  Journal Articles
• Decreasing Mortality With Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: The Mayo Clinic Experience From 1991 Through 1997  Conferences
• Determinants of masked hypertension in hypertensive patients treated in a primary care setting  Journal Articles
• Diabetes and the HOPE study: implications for macrovascular and microvascular disease.  Journal Articles
• Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registry  Journal Articles
• Diet and Kidney Disease in High-Risk Individuals With Type 2 Diabetes Mellitus  Journal Articles
• Digoxin in heart failure: results of the recent digoxin investigation group trial in the context of other treatments for heart failure  Journal Articles
• Discordance Between Physicians' Estimation of Patient Cardiovascular Risk and Use of Evidence-Based Medical Therapy  Journal Articles
• Does Renin‐Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case–Control Study  Journal Articles
• Does spironolactone reduce the risk of urinary tract cancers in hypertensive patients?  Journal Articles
• Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions  Journal Articles
• Dual Renin-Angiotensin System Blockade in Heart Failure  Journal Articles
• Dual inhibition of the renin–angiotensin system in high-risk diabetes and risk for stroke and other outcomes  Journal Articles
• Dysglycemia and a History of Reproductive Risk Factors  Journal Articles
• Early Versus Delayed Enalapril in Patients With Left Ventricular Systolic Dysfunction: Impact on Morbidity and Mortality 15 Years After the SOLVD Trial  Journal Articles
• Effect of Angiotensin-Converting Enzyme Inhibitors in Left Ventricular Dysfunction  Journal Articles
• Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery  Journal Articles
• Effect of Ramipril and of Rosiglitazone on Carotid Intima-Media Thickness in People With Impaired Glucose Tolerance or Impaired Fasting Glucose  Journal Articles
• Effect of Ramipril in Reducing Sudden Deaths and Nonfatal Cardiac Arrests in High-Risk Individuals Without Heart Failure or Left Ventricular Dysfunction  Journal Articles
• Effect of Ramipril on Cardiovascular Events in High-Risk Patients  Journal Articles
• Effect of Ramipril on the Incidence of Diabetes  Journal Articles
• Effect of Ramipril on the Incidence of Diabetes  Journal Articles
• Effect of acute angiotensin converting enzyme inhibition on left ventricular filling in patients with congestive heart failure. Relation to right ventricular volumes.  Journal Articles
• Effect of angiotensin-converting enzyme inhibition on C-reactive protein levels: The Ramipril C-Reactive pRotein Randomized evaluation (4R) trial results  Journal Articles
• Effect of angiotensin‐converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction—a meta‐analysis  Journal Articles
• Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.  Journal Articles
• Effect of candesartan on New York Heart Association functional classResults of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme  Journal Articles
• Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure  Journal Articles
• Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study  Journal Articles
• Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients  Journal Articles
• Effect of long-term therapy with ramipril in high-risk women  Journal Articles
• Effectiveness and risk of ARB and ACEi among different ethnic groups in England: A reference trial (ONTARGET) emulation analysis using UK Clinical Practice Research Datalink Aurum-linked data.  Journal Articles
• Effects of ACE Inhibitors on Mortality When Started in the Early Phase of Myocardial Infarction: Evidence from the Larger Randomized Controlled Trials  Journal Articles
• Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial  Journal Articles
• Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials  Journal Articles
• Effects of Centrally Acting Angiotensin Converting Enzyme Inhibitors on Functional Decline in Patients with Alzheimer's Disease  Journal Articles
• Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose  Journal Articles
• Effects of Ramipril and Vitamin E on Atherosclerosis  Journal Articles
• Effects of Ramipril on Coronary Events in High-Risk Persons  Journal Articles
• Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes  Journal Articles
• Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease  Journal Articles
• Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial  Journal Articles
• Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients  Journal Articles
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial  Journal Articles
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial  Journal Articles
• Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme  Journal Articles
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials  Journal Articles
• Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker  Journal Articles
• Effects of isometric handgrip training among people medicated for hypertension: a multilevel analysis  Journal Articles
• Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review  Journal Articles
• Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography  Journal Articles
• Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease  Journal Articles
• Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy  Journal Articles
• Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction  Journal Articles
• Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals  Journal Articles
• Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.  Journal Articles
• Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.  Journal Articles
• Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial  Journal Articles
• Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial  Journal Articles
• Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin‐converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)‐Added trial  Journal Articles
• Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure  Journal Articles
• Emerging approaches in preventing cardiovascular disease  Journal Articles
• Emerging approaches in the prevention of atherosclerotic cardiovascular diseases.  Journal Articles
• Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.  Journal Articles
• Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial  Journal Articles
• Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction.  Journal Articles
• Endothelium-dependent relaxation factor released by perivascular adipose tissue  Journal Articles
• Epidemiology of Decompensated Heart Failure in a Single Community in the Northeastern United States  Journal Articles
• Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both  Journal Articles
• Evidence based cardiology: Prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction  Journal Articles
• Exploring design-related bias in clinical studies on receptor genetic polymorphism of hypertension  Journal Articles
• Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis—Results from the International Scleroderma Renal Crisis Survey  Journal Articles
• Fatal neonatal renal failure due to maternal enalapril ingestion  Journal Articles
• From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)  Journal Articles
• From the hope to the ontarget and the transcend studies: challenges in improving prognosis  Journal Articles
• Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema  Journal Articles
• Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk  Journal Articles
• Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: Results from the ONTARGET/TRANSCEND Research Programme  Journal Articles
• Guideline-Recommended Therapy Following Hospitalization for Heart Failure  Journal Articles
• HEART FAILURE SOCIETY OF AMERICA (HFSA) PRACTICE GUIDELINES  Journal Articles
• Heart failure and shock complicating acute coronary syndromes  Journal Articles
• Heart failure between 1986 and 1994: Temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center  Journal Articles
• Heart failure.  Journal Articles
• Heart failure.  Journal Articles
• Heart failure.  Journal Articles
• Heart failure.  Journal Articles
• Heart failure.  Journal Articles
• Heart failure.  Journal Articles
• Heart failure.  Journal Articles
• Heart failure.  Journal Articles
• Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND  Journal Articles
• Hiding in plain sight—wildlife as a neglected reservoir and pathway for the spread of antimicrobial resistance: a narrative review  Journal Articles
• High-dose versus low-dose angiotensin converting enzyme inhibitors in heart failure: systematic review and meta-analysis  Journal Articles
• Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study  Journal Articles
• Hyperkalemia with Mineralocorticoid Receptor Antagonist Use in People with CKD  Journal Articles
• Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study  Journal Articles
• Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage  Journal Articles
• ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction  Journal Articles
• Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors  Journal Articles
• Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer  Journal Articles
• Impact of Estimated GFR Reporting on Patients, Clinicians, and Health-Care Systems: A Systematic Review  Journal Articles
• Impact of Ramipril on the Circadian Periodicity of Acute Myocardial Infarction  Journal Articles
• Impact of Sex on Cardiovascular Outcome in Patients at High Cardiovascular Risk  Journal Articles
• Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial  Journal Articles
• Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial  Journal Articles
• Impact of diabetes, angiotensin‐converting enzyme inhibitor or angiotensin II receptor blocker use, and statin use on presentation and outcomes in patients with giant cell arteritis  Conferences
• Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease  Journal Articles
• Impact of ramipril on the incidence of atrial fibrillation: Results of the Heart Outcomes Prevention Evaluation study  Journal Articles
• Implications of Diabetes in Patients With Acute Coronary Syndromes<subtitle>The Global Registry of Acute Coronary Events</subtitle>  Journal Articles
• Improved Outcomes With Early Collaborative Care of Ambulatory Heart Failure Patients Discharged From the Emergency Department  Journal Articles
• In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular Events  Journal Articles
• Increasing Use of Single and Combination Medical Therapy in Patients Hospitalized for Acute Myocardial Infarction in the 21st Century<subtitle>A Multinational Perspective</subtitle>  Journal Articles
• Indications for ACE Inhibitors in the Early Treatment of Acute Myocardial Infarction  Journal Articles
• Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection Fraction  Journal Articles
• Inhibition of angiotensin-converting enzyme by captopril: A novel approach to reduce ischemia-reperfusion injury after lung transplantation  Journal Articles
• Initial data supporting the design of the Candesartan in Heart failure — Assessment of Reduction in Mortality and morbidity (CHARM) programme  Journal Articles
• Insights into the contemporary epidemiology and outpatient management of congestive heart failure  Journal Articles
• Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial  Journal Articles
• Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy  Journal Articles
• Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction  Journal Articles
• Is the jury out? Class specific differences on coronary outcomes with ACE-inhibitors and ARBs: insight from meta-analysis and The Blood Pressure Lowering Treatment Trialists' CollaborationThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.  Journal Articles
• Is therapy of people with chronic kidney disease ONTARGET?  Journal Articles
• Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations  Journal Articles
• Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])  Journal Articles
• Length of Initial Prescription at Hospital Discharge and Long-term Medication Adherence for Elderly Patients With Coronary Artery Disease: A Population-Level Study  Journal Articles
• Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke  Journal Articles
• Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis  Journal Articles
• Long-Term Effects of Ramipril on Cardiovascular Events and on Diabetes  Journal Articles
• Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients  Journal Articles
• Management of acute coronary syndromes in developing countries: ACute Coronary Events—a multinational Survey of current management Strategies  Journal Articles
• Management of congestive heart failure  Journal Articles
• Management of heart failure in Canadian long-term care facilities.  Journal Articles
• Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: The role of adipocyte-derived angiotensin II  Journal Articles
• Medical Therapy for Chronic Congestive Heart Failure  Journal Articles
• Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization Therapy  Journal Articles
• Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure  Journal Articles
• Mineralocorticoid Receptor Antagonists in CKD: In Need of a Few Large Trials  Journal Articles
• Missed opportunities for the secondary prevention of cardiovascular disease in Canada  Journal Articles
• Modifying the natural history of atherosclerosis: the SECURE trial.  Journal Articles
• Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor–Based Regimens  Journal Articles
• More than just hype.  Journal Articles
• Net Health Plan Savings From Reference Pricing for Angiotensin-Converting Enzyme Inhibitors in Elderly British Columbia Residents  Journal Articles
• No Increase in Adverse Events During Aliskiren Use Among Ontario Patients Receiving Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers  Journal Articles
• Optimal Medical Therapy with or without PCI for Stable Coronary Disease  Journal Articles
• Outcomes of Acute Coronary Syndrome in a Large Canadian Cohort: Impact of Chronic Renal Insufficiency, Cardiac Interventions, and Anemia  Conferences
• Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials  Journal Articles
• Pathophysiologic and therapeutic importance of tissue ACE: a consensus report.  Journal Articles
• Pathophysiology and management of angiotensin-converting enzyme inhibitor-associated refractory hypotension during the perioperative period.  Journal Articles
• Patterns of angiotensin‐converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure  Journal Articles
• Patterns of medical therapy in patients with peripheral artery disease in a tertiary care centre in Canada  Journal Articles
• Perindopril treatment in the prevention of stroke in experimental animals  Journal Articles
• Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack  Journal Articles
• Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications  Journal Articles
• Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies.  Journal Articles
• Physicians' recommendations for patients who undergo noncardiac surgery.  Journal Articles
• Pollen Count and Presentation of Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema  Journal Articles
• Practical recommendations for the use of ACE inhibitors, beta‐blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice  Journal Articles
• Pre-Hospital Cardiac Arrest in Acute Coronary Syndromes: Insights from the Global Registry of Acute Coronary Events and the Canadian Registry of Acute Coronary Events  Journal Articles
• Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery  Journal Articles
• Presentation, Diagnosis, and Medical Management of Heart Failure in Children: Canadian Cardiovascular Society Guidelines  Journal Articles
• Preventing cardiovascular disease in primary care: Role of a national risk factor management program  Journal Articles
• Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors  Journal Articles
• Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers  Journal Articles
• Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study  Journal Articles
• Prevention of stroke and preservation of the functions of cerebral arteries by treatment with perindopril in stroke-prone spontaneously hypertensive rats  Journal Articles
• Prevention of stroke with perindopril treatment in stroke-prone spontaneously hypertensive rats.  Journal Articles
• Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular Dysfunction  Journal Articles
• Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study  Journal Articles
• Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study  Journal Articles
• Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study  Journal Articles
• Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury  Journal Articles
• RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection  Journal Articles
• Ramipril and Risk of Diabetes—Reply  Journal Articles
• Ramipril and the Development of Diabetes  Journal Articles
• Ramipril in the treatment of vascular diseases  Journal Articles
• Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors  Journal Articles
• Rationale and Design of a Large Study to Evaluate the Renal and Cardiovascular Effects of an ACE Inhibitor and Vitamin E in High-Risk Patients With Diabetes: The MICRO-HOPE Study  Journal Articles
• Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators.  Journal Articles
• Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation.  Journal Articles
• Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial  Journal Articles
• Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)  Journal Articles
• Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials  Journal Articles
• Recent advances in the drug treatment of heart failure  Journal Articles
• Recurrent events in meta-analysis of multiple clinical trials.  Journal Articles
• Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor Ramipril  Journal Articles
• Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE  Journal Articles
• Regular review: Drug treatment in heart failure  Journal Articles
• Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial  Journal Articles
• Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients  Journal Articles
• Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure  Journal Articles
• Renal Failure, Chronic  Journal Articles
• Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial  Journal Articles
• Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk  Journal Articles
• Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial  Journal Articles
• Renin Angiotensin Aldosterone System Inhibition in Controlling Dementia-Related Cognitive Decline  Journal Articles
• Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies  Journal Articles
• Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part VI: Treatment  Journal Articles
• Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD  Journal Articles
• Revisiting Race and the Benefit of RAS Blockade in Heart Failure  Journal Articles
• Risk Factors, Use of Preventive Drugs, and Cardiovascular Events in Diabetes Mellitus: The PURE Türkiye Cohort  Journal Articles
• Risk of Hospitalization for Community Acquired Pneumonia with Renin-Angiotensin Blockade in Elderly Patients: A Population-Based Study  Journal Articles
• Role of Angiotensin Converting Enzyme Inhibitors in Patients with Left Ventricular Dysfunction and Congestive Heart Failure  Journal Articles
• Role of Renin-Angiotensin System Blockade in Atherosclerotic Renal Artery Stenosis and Renovascular Hypertension  Journal Articles
• Role of Renin-Angiotensin System Blockade in Patients With Diabetes Mellitus  Journal Articles
• Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.  Journal Articles
• Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE Study  Journal Articles
• Sex-specific association of cardiovascular drug doses with adverse outcomes in atrial fibrillation  Journal Articles
• Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: Substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND)  Journal Articles
• Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?  Journal Articles
• Should patients with stable coronary artery disease be treated with ACE inhibitor therapy?  Journal Articles
• Should treatment for heart failure with preserved ejection fraction differ from that for heart failure with reduced ejection fraction?  Journal Articles
• Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks atter acute myocardial infarction: The GISSI-3 trial  Journal Articles
• Skeletal muscle-endothelial cell cross talk through angiotensin II  Journal Articles
• Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study  Journal Articles
• Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care  Journal Articles
• Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes  Journal Articles
• Studies of left ventricular dysfunction (SOLVD) registry: Rationale, design, methods and description of baseline characteristics  Journal Articles
• Study Design and Baseline Characteristics of the Study to Evaluate Carotid Ultrasound Changes in Patients Treated with Ramipril and Vitamin E: SECURE**This study was supported by Research Grant Ul-12363 from the Medicine Research Council of Canada, Ottawa; and by Hoechst Marion Roussel, Laval, Canada, Inc.  Journal Articles
• Study on propionyl-?-carnitine in chronic heart failure  Journal Articles
• Summary of Randomized Trials of Angiotensin Converting Enzyme Inhibitors  Journal Articles
• Surgical biology for the clinician: vascular effects of immunosuppression.  Journal Articles
• Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk  Journal Articles
• Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease  Journal Articles
• Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events  Journal Articles
• Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events  Journal Articles
• Telmisartan, ramipril, or both in high-risk Chinese patients: analysis of ONTARGET China data.  Journal Articles
• The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.  Journal Articles
• The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure.  Journal Articles
• The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs  Journal Articles
• The HOPE (Heart Outcomes Prevention Evaluation) Study and its Consequences  Journal Articles
• The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.  Journal Articles
• The HOPE study and diabetes  Journal Articles
• The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct  Journal Articles
• The Mini‐Mental State Examination, Clinical Factors, and Motor Vehicle Crash Risk  Journal Articles
• The Prognostic Significance of Bundle Branch Block in High‐Risk Chronic Stable Vascular Disease Patients: A Report from the HOPE Trial  Journal Articles
• The Role of Angiotensin II Receptor Blockers in the Treatment of Heart Failure Patients  Journal Articles
• The Treatment of Heart Failure  Journal Articles
• The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics  Journal Articles
• The clinical relevance of pharmacological blood pressure lowering mechanisms.  Journal Articles
• The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study  Journal Articles
• The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis  Journal Articles
• The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy  Journal Articles
• The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial  Journal Articles
• The effect of treatment on survival in congestive heart failure  Journal Articles
• The management of congestive heart failure  Journal Articles
• The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study  Journal Articles
• The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect  Journal Articles
• The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis  Journal Articles
• The relevance of subgroup-specific treatment effects: The Studies Of Left Ventricular Dysfunction (SOLVD) revisited  Journal Articles
• The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data  Journal Articles
• The therapeutic potential of angiotensin II receptor blockers in the treatment of heart failure  Journal Articles
• To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy.  Journal Articles
• Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting  Journal Articles
• Two decades of progress in preventing vascular disease  Journal Articles
• Understanding Antihypertensive Medication Use after Living Kidney Donation through Linked National Registry and Pharmacy Claims Data  Journal Articles
• Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers and Cardiovascular Outcomes in Chronic Dialysis Patients: A Population-Based Cohort Study  Journal Articles
• Use of Combination Evidence-Based Medical Therapy Prior to Acute Myocardial Infarction (from the National Registry of Myocardial Infarction-4)  Journal Articles
• Use of Disease-Modifying Therapies in Patients Hospitalized with Heart Failure: A Population-Based Perspective  Journal Articles
• Use of ramipril in preventing stroke: double blind randomised trial  Journal Articles
• Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey  Journal Articles
• Usefulness of Temporal Changes in Neurohormones as Markers of Ventricular Remodeling and Prognosis in Patients With Left Ventricular Systolic Dysfunction and Heart Failure Receiving Either Candesartan or Enalapril or Both  Journal Articles
• Using exercise endpoints in heart failure trials: design considerations  Journal Articles
• Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both  Journal Articles
• Who is fooling us?  Journal Articles
• Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery  Journal Articles
• [After the HOPE Study. ACE inhibitor now for every diabetic patient?. Interview by Dr. Dirk Einecke].  Journal Articles
• [Effects of benazepril, a new ACE inhibitor, in effort angina pectoris].  Journal Articles